Planta Med 2010; 76(15): 1678-1682
DOI: 10.1055/s-0030-1249939
Pharmacology
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Exocarpic Acid Inhibits Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

Michael Koch1 , Tim S. Bugni2 , Mohammad Sondossi3 , Chris M. Ireland2 , Louis R. Barrows1
  • 1Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, USA
  • 2Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah, USA
  • 3Department of Microbiology, Weber State University, Ogden, Utah, USA
Further Information

Publication History

received January 26, 2010 revised April 7, 2010

accepted April 16, 2010

Publication Date:
26 May 2010 (online)

Preview

Abstract

Exocarpic acid (13E-octadecene-9,11-diynoic acid) from Exocarpos latifolius R.Br. (Santalaceae) was previously shown to have specific antimycobacterial activity. Microarray data suggested inhibition of fatty acid metabolism as a potential mode of action. Experiments designed to elucidate the mechanism of action showed that exocarpic acid was effective at inhibition of mycolic acid biosynthesis and did not act by dissipating the proton gradient in treated M. tuberculosis. Amide derivatives of exocarpic acid displayed similar properties to exocarpic acid, while other polyacetylenic fatty acids varied in their effects on mycolic acid biosynthesis.

References

Prof. Dr. Louis R. Barrows

Department of Pharmacology and Toxicology
University of Utah

30 S. 2000 E Rm 201

Salt Lake City, UT 84112

USA

Phone: + 1 801 581 4547

Fax: + 1 801 585 5111

Email: louis.barrows@pharm.utah.edu